245 related articles for article (PubMed ID: 21683340)
1. Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts.
de Moraes M; de Lucena HF; de Azevedo PR; Queiroz LM; Costa Ade L
Arch Oral Biol; 2011 Nov; 56(11):1256-63. PubMed ID: 21683340
[TBL] [Abstract][Full Text] [Related]
2. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
[TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts.
de Moraes M; de Matos FR; de Souza LB; de Almeida Freitas R; de Lisboa Lopes Costa A
J Oral Pathol Med; 2013 Jul; 42(6):468-73. PubMed ID: 23278112
[TBL] [Abstract][Full Text] [Related]
4. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors.
Andrade FR; Sousa DP; Mendonça EF; Silva TA; Lara VS; Batista AC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Oct; 106(4):548-55. PubMed ID: 18928898
[TBL] [Abstract][Full Text] [Related]
5. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas.
Menezes R; Bramante CM; da Silva Paiva KB; Letra A; Carneiro E; Fernando Zambuzzi W; Granjeiro JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):404-9. PubMed ID: 16920551
[TBL] [Abstract][Full Text] [Related]
6. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
Armada L; Marotta Pdos S; Pires FR; Siqueira JF
J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
[TBL] [Abstract][Full Text] [Related]
7. The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas.
Tekkesin MS; Mutlu S; Olgac V
Head Neck Pathol; 2011 Sep; 5(3):248-53. PubMed ID: 21643971
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors.
de Matos FR; de Moraes M; das Neves Silva EB; Galvão HC; de Almeida Freitas R
J Oral Maxillofac Surg; 2013 Nov; 71(11):1886-92. PubMed ID: 23992784
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
Ikeda T; Utsuyama M; Hirokawa K
J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
[TBL] [Abstract][Full Text] [Related]
10. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
[TBL] [Abstract][Full Text] [Related]
11. OPG, RANK and RANK ligand expression in thyroid lesions.
Heymann MF; Riet A; Le Goff B; Battaglia S; Paineau J; Heymann D
Regul Pept; 2008 Jun; 148(1-3):46-53. PubMed ID: 18367263
[TBL] [Abstract][Full Text] [Related]
12. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts.
Nonaka CF; Cavalcante RB; Nogueira RL; de Souza LB; Pinto LP
Arch Oral Biol; 2012 Mar; 57(3):230-7. PubMed ID: 21871606
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma.
Chuang FH; Hsue SS; Wu CW; Chen YK
J Oral Pathol Med; 2009 Nov; 38(10):753-8. PubMed ID: 19566744
[TBL] [Abstract][Full Text] [Related]
15. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
16. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
17. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
18. Biology of RANK, RANKL, and osteoprotegerin.
Boyce BF; Xing L
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S1. PubMed ID: 17634140
[TBL] [Abstract][Full Text] [Related]
19. Expression of RANKL and OPG in middle ear cholesteatoma tissue.
Jeong JH; Park CW; Tae K; Lee SH; Shin DH; Kim KR; Park YW
Laryngoscope; 2006 Jul; 116(7):1180-4. PubMed ID: 16826057
[TBL] [Abstract][Full Text] [Related]
20. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells.
Fan R; Sun B; Zhang CF; Lü YL; Xuan W; Wang QQ; Yin XZ
Chin Med J (Engl); 2011 Jul; 124(14):2162-6. PubMed ID: 21933620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
